The Trump administration is reportedly getting set to nominate a new FDA commissioner.
Several weeks ago, reports emerged that Stephen Hahn, a chief medical officer from MD Anderson in Houston, had become the frontrunner for the position. Now, sources familiar with the matter have indicated that Trump will nominate Hahn, pending results from an ongoing vetting process.
Ned Sharpless, the director of the National Cancer Institute, has been filling in as the acting FDA commish since Scott Gottlieb wrapped his revered two-year run in the role. Sharpless had received public support from Gottlieb, other former FDA commissioners and some patient advocacy group. But Trump seems to have ultimately settled on Hahn, a longtime Republican campaign contributor.
The Trump administration has until Nov. 1 to make a formal nomination.
